NCT01278693

Effect of Oral L-carnitine Supplement on Lipid Profile, Anemia, and Quality of Life of Patients

Study of Treatment of Dyslipidemia for Hemodialysis

• Status: Completed
• Phase: Phase 2
• Study type: Interventional
• Enrollment: 54 (actual)
• Sponsor: Isfahan University of Medical Sciences · Academic / Other
• Sex: Female
• Age: 18 Years – 75 Years
• Healthy volunteers: Accepted

Summary

The purpose of this study is to determine Effect of oral L-carnitine supplement on lipid profile, anemia, and quality of life.

Detailed description

In patients under maintenance hemodialysis several factors reduce the body stored carnitine which in turn affected dyslipidemia, anemia, and general health in these patients. The investigators evaluated the effect of oral L-carnitine supplementation on lipid profiles, anemia, and quality of life in hemodialysis patients.

Conditions

• Complication of Hemodialysis

Interventions

Type	Name	Description
DRUG	L-carnitine	500 mg,twice daily, 16 weeks
DRUG	placebo	500 mg,twice daily, 16 weeks.

Timeline

• Start date: 2009-08-01
• Primary completion: 2010-09-01
• Completion: 2010-09-01
• First posted: 2011-01-19
• Last updated: 2011-01-19

Locations

1 site across 1 country: Iran